Keenova Launches Mixed Reality Tool to Boost Dupuytren's Contracture Awareness
Event summary
- Keenova Therapeutics debuts DC Hand Anatomy, a mixed reality educational tool for Dupuytren's contracture, at the ASSH Annual Meeting in September 2026.
- The company supports the 2nd Annual National Hand Health Month with digital outreach, educational content, and ASSH meeting activations.
- Dupuytren's contracture affects an estimated 13 million Americans, with many delaying treatment due to symptom dismissal.
- Keenova aims to promote earlier intervention and appropriate treatment through awareness initiatives.
The big picture
Keenova's mixed reality tool and awareness initiatives reflect a broader trend in healthcare towards leveraging immersive technology for patient education and early intervention. The company's focus on Dupuytren's contracture aligns with its strategy of addressing rare or unmet medical conditions. The success of these efforts could influence how other pharmaceutical companies approach patient engagement and disease awareness.
What we're watching
- Adoption Pace
- How quickly healthcare professionals will integrate the mixed reality tool into their practice and education.
- Awareness Impact
- Whether the campaign will successfully reduce treatment delays for Dupuytren's contracture patients.
- Technological Leadership
- Keenova's ability to sustain its position as a leader in innovative healthcare education through technology.
Related topics